C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 237/36 (2006.01) A61K 31/166 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2629348
The present invention discloses novel compounds of Formula I, or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like.
La présente invention concerne de nouveaux composés de formule I, ou leurs sels pharmaceutiquement acceptables, qui possèdent une activité d'antagoniste ou d'agoniste inverse des récepteurs du glucagon, ainsi que des procédés de préparation de ces composés. Dans un autre mode de réalisation, l'invention concerne des compositions pharmaceutiques comprenant des composés de formule I, ainsi que des procédés les utilisant pour traiter des troubles diabétiques et d'autres troubles métaboliques liés au glucagon.
Conner Scott Eugene
Li Jianke
Zhu Guoxin
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Glucagon receptor antagonists, preparation and therapeutic uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucagon receptor antagonists, preparation and therapeutic uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucagon receptor antagonists, preparation and therapeutic uses will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1993713